All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 45.55
(-1.83%)
TWD 45.55
(-1.83%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 375.98 Million TWD | -21.32% |
| 2022 | 477.84 Million TWD | 25.21% |
| 2021 | 381.63 Million TWD | 37.74% |
| 2020 | 277.06 Million TWD | 1.52% |
| 2019 | 272.91 Million TWD | -30.34% |
| 2018 | 391.77 Million TWD | 13.62% |
| 2017 | 344.8 Million TWD | 4.23% |
| 2016 | 330.82 Million TWD | -2.41% |
| 2015 | 338.97 Million TWD | -13.43% |
| 2014 | 391.56 Million TWD | 30.44% |
| 2013 | 300.18 Million TWD | 3.67% |
| 2012 | 289.56 Million TWD | 25.48% |
| 2011 | 230.75 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 110 Million TWD | -5.09% |
| 2024 Q1 | 109.44 Million TWD | 9.27% |
| 2023 Q3 | 106.56 Million TWD | 15.53% |
| 2023 Q2 | 92.24 Million TWD | 2.74% |
| 2023 Q1 | 89.77 Million TWD | -21.54% |
| 2023 FY | 375.98 Million TWD | -21.32% |
| 2023 Q4 | 100.15 Million TWD | -6.01% |
| 2022 Q1 | 99.25 Million TWD | -19.35% |
| 2022 FY | 477.84 Million TWD | 25.21% |
| 2022 Q4 | 114.43 Million TWD | -23.78% |
| 2022 Q2 | 114.01 Million TWD | 14.87% |
| 2022 Q3 | 150.14 Million TWD | 31.68% |
| 2021 Q3 | 94.42 Million TWD | 9.94% |
| 2021 Q4 | 123.06 Million TWD | 30.33% |
| 2021 FY | 381.63 Million TWD | 37.74% |
| 2021 Q2 | 85.88 Million TWD | 9.77% |
| 2021 Q1 | 78.24 Million TWD | -13.4% |
| 2020 Q3 | 73.73 Million TWD | 29.51% |
| 2020 Q4 | 90.35 Million TWD | 22.54% |
| 2020 Q1 | 56.03 Million TWD | -14.16% |
| 2020 FY | 277.06 Million TWD | 1.52% |
| 2020 Q2 | 56.93 Million TWD | 1.6% |
| 2019 Q3 | 62.19 Million TWD | -18.44% |
| 2019 Q4 | 65.28 Million TWD | 4.97% |
| 2019 FY | 272.91 Million TWD | -30.34% |
| 2019 Q1 | 69.19 Million TWD | -10.34% |
| 2019 Q2 | 76.25 Million TWD | 10.2% |
| 2018 Q2 | 98.93 Million TWD | -7.44% |
| 2018 FY | 391.77 Million TWD | 13.62% |
| 2018 Q4 | 77.16 Million TWD | -29.07% |
| 2018 Q3 | 108.79 Million TWD | 9.97% |
| 2018 Q1 | 106.88 Million TWD | 15.53% |
| 2017 Q3 | 97.81 Million TWD | 12.66% |
| 2017 Q2 | 86.82 Million TWD | 28.35% |
| 2017 Q1 | 67.64 Million TWD | 28.22% |
| 2017 FY | 344.8 Million TWD | 4.23% |
| 2017 Q4 | 92.51 Million TWD | -5.42% |
| 2016 Q2 | 113.87 Million TWD | 36.25% |
| 2016 Q3 | 80.62 Million TWD | -29.2% |
| 2016 Q4 | 52.75 Million TWD | -34.56% |
| 2016 Q1 | 83.57 Million TWD | 5.43% |
| 2016 FY | 330.82 Million TWD | -2.41% |
| 2015 FY | 338.97 Million TWD | -13.43% |
| 2015 Q2 | 96.52 Million TWD | 22.41% |
| 2015 Q4 | 79.27 Million TWD | -6.0% |
| 2015 Q3 | 84.32 Million TWD | -12.63% |
| 2015 Q1 | 78.85 Million TWD | 0.0% |
| 2014 FY | 391.56 Million TWD | 30.44% |
| 2013 FY | 300.18 Million TWD | 3.67% |
| 2013 Q1 | 64.45 Million TWD | -27.78% |
| 2012 FY | 289.56 Million TWD | 25.48% |
| 2012 Q4 | 89.25 Million TWD | 0.0% |
| 2011 FY | 230.75 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sinon Corporation | 5.19 Billion TWD | 92.769% |
| Taiwan Fertilizer Co., Ltd. | 1.3 Billion TWD | 71.29% |
| CH Biotech R&D Co., Ltd. | 694.23 Million TWD | 45.841% |